Overview
Melanos Care is a Deep-Tech biotech platform that develops bio-identical melanin and advanced active ingredients for skincare, focusing on protection, anti-aging, and natural aesthetics. The company offers a melanin-based cream that provides long-lasting UV protection, natural tanning, and anti-aging benefits, utilizing proprietary stem cell technology for cost-effective production. Additionally, they have created a cinnamic acid derivative that effectively reduces melanin content, addressing hyperpigmentation with superior efficacy compared to global market leaders.
Financials
Revenue history
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2023-11-17. Active
24 1090 2590 0000 0001 5584 6652
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
4 public aid cases recorded, with a total value of $546,963.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 9, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $5,726$5,726 | Fundacja Klaster Lifescience Kraków | |
| Jan 28, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $2,857$2,857 | Fundacja Klaster Lifescience Kraków | |
| Dec 15, 2025 | Aid for SMEs for innovation support | $498.3K$498,299 | Prezes Banku Gospodarstwa Krajowego |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-10-01 | Opracowanie i walidacja zoptymalizowanego protokołu liofilizacji dla mikropęcherzyków biologicznych (melanosomów oraz egzosomów) | $40,080$40,080 | Fundusze Europejskie dla Małopolski 2021-2027 |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
If the company has a one-person management board, the only member of the management board is authorised to represent the company independently. If the management board consists of two or more members, then: (i) if the amount of the liability incurred or the performance rendered does not exceed PLN 25,000.00, the company may be represented by one person; (ii) if the amount of the liability incurred or the performance rendered exceeds PLN 25,000.00, joint action of two members of the management board or joint action of one member of the management board with a commercial proxy is required to make declarations of will and sign documents on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marcin Liwoch (53) | 22 | $297.14 | 8.5938% |
Marcin Marek Majka (54) | 126 | $1,701.78 | 49.2188% |
Konrad Grzegorz Szczukiewicz (37) | 32 | $432.20 | 12.5% |
Piotr Antoni Sznelewski (57) | 24 | $324.15 | 9.375% |
Others | 52 | $702.32 | 20.3124% |
The articles of association require board approval for share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Change history
| Date | Event | |
|---|---|---|
| 2024-05-14 | Share capital change (10,000.00 PLN → 10,800.00 PLN) | |
| 2023-10-24 | Entered in the register |
FAQ
Last updated: 2026-07-15